PEG-recombinant uricase (Chongqing Fagen Biopharmaceutical)

N/A

Report date: 2025/03/20 15:27:17

Base Information

Drug NamePEG-recombinant uricase (Chongqing Fagen Biopharmaceutical)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionUric acid modulatorsUric acid stimulants
TargetsUric acid
Therapy Area/IndicationsGout
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChongqing Fujin Biological Medicine Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChongqing Fujin Biological Medicine Co Ltd
Inactive CompaniesN/A
Active IndicationsGout
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A